ELOVL1 anticorps (AA 82-175) (FITC)

N° du produit ABIN7151558

Détail du produit anti-ELOVL1 anticorps (FITC)

Antigène: ELOVL1 (ELOVL Fatty Acid Elongase 1 (ELOVL1))

Épitope: AA 82-175

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ELOVL1 est conjugé à/à la FITC

Application: Veuillez nous consulter SVP

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Elongation of very long chain fatty acids protein 1 protein (82-175AA)

Isotype: IgG

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur ELOVL1

Antigène: ELOVL1 (ELOVL Fatty Acid Elongase 1 (ELOVL1))

Autre désignation: ELOVL1 (ELOVL1 Produits)

Synonymes: anticorps AA407424, anticorps BB151133, anticorps Ssc1, anticorps elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 1, anticorps ELOVL fatty acid elongase 1, anticorps Elovl1, anticorps ELOVL1

Sujet:

Background: Catalyzes the first and rate-limiting reaction of the four that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process, allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids/VLCFAs per cycle. Condensing enzyme that exhibits activity toward saturated C18 to C26 acyl-CoA substrates, with the highest activity towards C22:0 acyl-CoA. May participate to the production of both saturated and monounsaturated VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. Important for saturated C24:0 and monounsaturated C24:1 sphingolipid synthesis. Indirectly inhibits RPE65 via production of VLCFAs.

Aliases: 3 keto acyl CoA synthase ELOVL1 antibody, 3-keto acyl-CoA synthase ELOVL1 antibody, CGI 88 antibody, Elongation of very long chain fatty acids (FEN1/Elo2 SUR4/Elo3 yeast) like 1 antibody, Elongation of very long chain fatty acids like 1 antibody, Elongation of very long chain fatty acids protein 1 antibody, ELOV1_HUMAN antibody, ELOVL 1 antibody, ELOVL FA elongase 1 antibody, ELOVL fatty acid elongase 1 antibody, ELOVL1 antibody, Ssc1 antibody, Ssc1, mouse, homolog of antibody, very long chain 3 oxoacyl CoA synthase 1 antibody, Very-long-chain 3-oxoacyl-CoA synthase 1 antibody

UniProt: Q9BW60